Urogen Pharma Ltd (URGN)

Urogen Pharma Ltd Azioni (URGN) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	20.18% 18.78	23.53	20.85	21.14	17.19
Cost Of Revenue	24.41% 1.728	2.286	2.367	2.443	2.265
Gross Profit	19.73% 17.05	21.24	18.48	18.70	14.93
Operating Expenses	19.36% 42.79	35.85	31.98	34.08	36.97
Benefits Costs and Expenses	11.65% 51.01	45.69	42.74	45.22	47.38
Costs And Expenses	11.65% 51.01	45.69	42.74	45.22	47.38
Operating Income/Loss	76.19% -25.74	-14.61	-13.50	-15.38	-22.05
Nonoperating Income/Loss	122.54% -0.183	0.812	0.071	-0.03	-0.015
Income/Loss From Continuing Operations Before Tax	45.44% -32.23	-22.16	-21.89	-24.08	-30.19
Income Tax Expense/Benefit	98.60% 0.054	3.854	-0.009	0.054	0.021
Income/Loss From Continuing Operations After Tax	24.10% -32.29	-26.02	-21.88	-24.14	-30.21
Net Income/Loss	24.10% -32.29	-26.02	-21.88	-24.14	-30.21
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1,248% 33.38	2.4756	32.30	23.46	23.28
Basic Earnings Per Share	46.97% -0.97	-0.66	-0.68	-1.03	-1.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-